PTPN11 and Insulin resistance: However, consistent with a role of SHP2 in promoting cellular insulin resistance by inhibiting insulin-evoked PI3K signaling, high sugar exposure-induced insulin-resistant hepatocytes overexpress SHP2 and display reduced PI3K/AKT signaling.